Harmonization of Flow Cytometric Minimal Residual Disease Assessment in Multiple Myeloma in Centers of Polish Myeloma Consortium

Minimal residual disease (MRD) status is now considered as one of the most relevant prognostic factors in multiple myeloma (MM) while MRD negativity became an important endpoint in clinical trials. Here, we report the results of the first study evaluating the reproducibility of high-sensitivity flow...

Descripción completa

Detalles Bibliográficos
Autores principales: Krzywdzińska, Agnieszka, Puła, Bartosz, Czyż, Anna, Krzymieniewska, Beata, Kiernicka-Parulska, Jolanta, Mierzwa, Anna, Szymczak, Donata, Milanowska, Aneta, Kiraga, Aleksandra, Kwiecień, Iwona, Zaleska, Joanna, Jamroziak, Krzysztof
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534749/
https://www.ncbi.nlm.nih.gov/pubmed/34679569
http://dx.doi.org/10.3390/diagnostics11101872

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534749/
https://www.ncbi.nlm.nih.gov/pubmed/34679569
http://dx.doi.org/10.3390/diagnostics11101872

Ejemplares similares